Loading...
Loading...
Browse all stories on DeepNewz
VisitWill David Joyner remain CEO of CVS Health by the end of 2024?
Yes • 50%
No • 50%
Official announcements from CVS Health or major financial news outlets
CVS Names David Joyner CEO as Shares Plunge 13% on Lower Earnings and Withdrawn Outlook
Oct 18, 2024, 10:45 AM
CVS Health has appointed David Joyner as its new Chief Executive Officer, replacing Karen Lynch, who stepped down after an agreement with the board. The company is backing away from its most recent 2024 outlook issued in August, as it grapples with lower-than-expected earnings. CVS announced that its preliminary third-quarter adjusted earnings per share are expected to be between $1.05 and $1.10, significantly below analysts' estimates of $1.70. The healthcare giant also cited higher medical cost trends, with a medical loss ratio of 95% compared to expectations of 91%. Following the news, CVS shares have plunged by over 13% in pre-market trading.
View original story
CEO • 25%
CFO • 25%
Head of Aetna • 25%
No major change • 25%
CEO resignation • 25%
Board restructuring • 25%
No change • 25%
Other changes • 25%
Tim Wentworth • 25%
John Standley • 25%
Rosalind Brewer • 25%
Other • 25%
$1.11 to $1.20 • 25%
Above $1.20 • 25%
Below $1.00 • 25%
$1.00 to $1.10 • 25%
93% to 95% • 25%
Below 90% • 25%
Above 95% • 25%
90% to 92% • 25%